Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same

Patent No. EP1301519 (titled "Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same") was filed by Gilead Sciences on Jul 20, 2001. The application was issued on Nov 10, 2021.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HEXAL PHARMA AGNov 25, 2015HUENGES
STRAWMANNov 24, 2015SHEARD
SWINDELL & PEARSONNov 23, 2015FRKELLY
TEVA PHARMACEUTICAL INDUSTRIES LTDNov 23, 2015D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1301519

GILEAD SCIENCES
Application Number
EP01961695A
Filing Date
Jul 20, 2001
Status
Patent Maintained As Amended
Oct 8, 2021
Publication Date
Nov 10, 2021